![D J Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
D J Kim
Plus aucun poste en cours
Historique de carrière de D J Kim
Anciens postes connus de D J Kim
Sociétés | Poste | Début | Fin |
---|---|---|---|
Chemgenomics, Inc. | Directeur Technique/Scientifique/R&D | - | - |
REXAHN PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2006 | - |
Formation de D J Kim
Seoul National University | Undergraduate Degree |
Korea Advanced Institute of Science & Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Corée du Sud | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Chemgenomics, Inc. |